EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Enhancing Diagnostic Accuracy in Sinonasal Neuroendocrine Tumors: The Case for DOTATATE PET Over FDG PET

Michael Sabbaj iD, Anandraj Kanwar, Jessica W Grayson iD, Nyall R London, Shirley Y Su, Carl H Snyderman iD, Brian D Thorp, Dennis Tang, David Gudis iD, Eric W Wang iD, Edward C Kuan, Garett W Choby iD und 1 weitere

International Forum of Allergy & Rhinology · 2025-10 · 15 (10) · 1023-1027

DOI: 10.1002/alr.70001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 18.07.2025. Verfasst von Michael Sabbaj und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Fluorodeoxyglucose F18, Positron-Emission Tomography, Organometallic Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms that arise from neuroendocrine cells and commonly originate in the GI tract, lungs, and pancreas, but can also present in the skull base and paranasal sinuses. While fluorodeoxyglucose positron emission tomography (FDG PET) scans are routinely used in the evaluation of sinonasal malignancies, their limitations in detecting recurrences near the cranium and cervical lymph node metastases in NETs such as olfactory neuroblastoma (ONB) and sinonasal neuroendocrine carcinomas (SNEC) have prompted the search for an alternative imaging modality. Somatostatin receptor 2 (SSTR2) is a membrane‐bound G protein expressed in several types of neuroendocrine and neural cells. Notably, it is also expressed almost ubiquitously in ONB and SNEC. Gallium‐68 DOTATATE PET scans (68Ga‐DOTATATE) utilize a somatostatin analog as a targeting imaging modality. The efficacy of 68Ga‐DOTATATE scan has been well established for gastrointestinal NETs, but its place in head and neck cancers is still under investigation. Importantly, SSTR2 expression also opens avenues for peptide receptor radionuclide therapy (PRRT), further broadening its clinical utility. Given the limitations of FDG PET scans, 68Ga‐DOTATATE PET scans should be incorporated into routine practice when staging and monitoring for recurrences in ONB and SNEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsFluorodeoxyglucose F18Positron-Emission TomographyOrganometallic CompoundsParanasal Sinus NeoplasmsNose NeoplasmsHumansReceptors, SomatostatinRadiopharmaceuticalsEsthesioneuroblastoma, Olfactory

Stichwörter der Autor:innen

Dotatateesthesioneuroblastomaneuroendocrine carcinomaoctreotideolfactory neuroblastomapositron‐emission tomographysomatostatin

Substanzen

gallium Ga 68 dotatateReceptors, SomatostatinFluorodeoxyglucose F18Organometallic CompoundsRadiopharmaceuticals

Autor:innen und Institutionen

  • University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Department of Radiology, New Orleans University Medical Center Hospital, New Orleans, Louisiana, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Alabama, Birmingham, Alabama, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Otolaryngology, Center for Skull Base Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Michael Sabbaj, Jessica W Grayson, Carl H Snyderman, David Gudis, Eric W Wang, Garett W Choby

Zitieren

APA

Sabbaj, M., Kanwar, A., Grayson, J. W., London, N. R., Su, S. Y., Snyderman, C. H., Thorp, B. D., Tang, D., Gudis, D., Wang, E. W., Kuan, E. C., Choby, G. W., & Geltzeiler, M. (2025). Enhancing Diagnostic Accuracy in Sinonasal Neuroendocrine Tumors: The Case for DOTATATE PET Over FDG PET. International Forum of Allergy & Rhinology, 15(10), 1023-1027. https://doi.org/10.1002/alr.70001

Vancouver

Sabbaj M, Kanwar A, Grayson JW, London NR, Su SY, Snyderman CH, et al. Enhancing Diagnostic Accuracy in Sinonasal Neuroendocrine Tumors: The Case for DOTATATE PET Over FDG PET. International Forum of Allergy & Rhinology. 2025;15(10):1023-1027. doi:10.1002/alr.70001

BibTeX
@article{Sabbaj2025,
  author = {Sabbaj, Michael and Kanwar, Anandraj and Grayson, Jessica W and London, Nyall R and Su, Shirley Y and Snyderman, Carl H and Thorp, Brian D and Tang, Dennis and Gudis, David and Wang, Eric W and Kuan, Edward C and Choby, Garett W and Geltzeiler, Mathew},
  title = {Enhancing Diagnostic Accuracy in Sinonasal Neuroendocrine Tumors: The Case for DOTATATE PET Over FDG PET},
  journal = {International Forum of Allergy & Rhinology},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1023--1027},
  doi = {10.1002/alr.70001}
}
Kostenlos starten →